60
Participants
Start Date
April 30, 2014
Primary Completion Date
October 31, 2015
Study Completion Date
October 31, 2015
Ticagrelor 180mg
The proposed study will have a prospective, randomized, parallel design in which patients on chronic ticagrelor therapy will be assigned to receive a reloading dose of 90 or 180 mg ticagrelor. Platelet function assays will be done following in vitro incubation with and without 500 nM cangrelor.
Ticagrelor 90mg
The proposed study will have a prospective, randomized, parallel design in which patients on chronic ticagrelor therapy will be assigned to receive a reloading dose of 90 or 180 mg ticagrelor. Platelet function assays will be done following in vitro incubation with and without 500 nM cangrelor.
Dominick Angiolillo, Jacksonville
Collaborators (1)
The Medicines Company
INDUSTRY
University of Florida
OTHER